MALIGNANT SOLID TUMORS
Clinical trials for MALIGNANT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMORS trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets hard-to-treat solid tumors
Disease control Not yet recruitingThis study tests a new drug, JCXH-211, injected directly into tumors along with an anti-PD-1 antibody given through an IV. It is for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the combination is safe and tolerable …
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New Dual-Target PET probe aims to sharpen cancer detection
Diagnosis Not yet recruitingThis study will test a new imaging agent called 68Ga-B6FA-01, which targets two different markers on cancer cells and their surroundings. The goal is to see if this probe can improve PET/CT scans for diagnosing and staging solid tumors. About 100 adults with newly diagnosed or re…
Matched conditions: MALIGNANT SOLID TUMORS
Sponsor: Zhongnan Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC